SEARCH

SEARCH BY CITATION

References

  • 1
    Hackett PH, Roach CR. Current concepts. High-altitude illness. N Engl J Med 2001; 345:107114.
  • 2
    Basnyat B, Murdoch DR. High-altitude illness. Lancet 2003; 361:19671974.
  • 3
    Gaillard S, Dellasanta P, Loutan L, Kayser B. Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt Med Biol 2004; 5:410419.
  • 4
    Pesce C, Leal C, Pinto H, et al. Determinants of acute mountain sickness and success on Mount Aconcagua. High Alt Med Biol 2005; 6:158166.
  • 5
    Hackett PH. Chapter 9: Medical problems of high altitude. In: DupontHL, SteffenR, eds. Textbook of travel medicine and health. Hamilton, Ontario: BC Decker, 1997:5162.
  • 6
    Basnyat B, Savard GK, Zafren K. Trends in the workload of the two high altitude aid posts in the Nepal Himalayas. J Travel Med 1999; 6:217222.
  • 7
    Vardy J, Vardy J, Judge K. Can knowledge protect against acute mountain sickness? J Public Health (Oxf) 2005; 27:366370.
  • 8
    Kuepper T, Wermelskirchen D, Beeker TH, et al. First aid knowledge of alpine mountaineers. Resuscitation 2003; 58:159169.
  • 9
    Glazer JL, Edgar C, Siegel MS. Awareness of altitude sickness among a sample of trekkers in Nepal. Wilderness Environ Med 2005; 16:132138.
  • 10
    Roach RC, Bartsch P, Oelz O, Hackett PH, Lake Louise AMS scoring consensus committee. The Lake Louise acute mountain sickness scoring system. In: SuttonJR, HoustonCS, CoatesG, eds. Hypoxia and molecular medicine. Burlington, VT: Charles S. Houston, 1993:272274.
  • 11
    Gertsch JH, Basnyat B, Johnson EW, et al. Randomised, double blind, placebo controlled comparison of ginko biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ 2004; 328:797801.
  • 12
    Dumont L, Mardirosoff C, Tramer MR. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review. BMJ 2000: 321:267272.
  • 13
    Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med 1993; 118:587592.
  • 14
    Dean AG, Yip R, Hoffman RE. High incidence of mild acute mountain sickness in conference attendees at 10,000 foot altitude. J Wilderness Med 1990; 1:8692.
  • 15
    Pigman EC, Karakla DW. Acute mountain sickness at intermediate altitude: military mountainous training. Am J Emerg Med 1990; 8:710.
  • 16
    Hamer DH, Connor BA. Travel health knowledge, attitudes and practices among United States travelers. J Travel Med 2004; 11:2326.
  • 17
    Wilder-Smith A, Khairullah NS, Song JH, et al. Travel health knowledge, attitudes and practices among Australasian travelers. J Travel Med 2004; 11:915.
  • 18
    Van Herck K, Van Damme P, Castelli F, et al. Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey. J Trav Med 2004; 11:38.
  • 19
    Schneider M, Bernasch D, Weymann J, et al. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 2002; 34:18861991.
  • 20
    Theis MK, Honigman B, Yip R, et al. Acute mountain sickness in children at 2835 meters. Am J Dis Child 1993; 147:143145.